Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1993-07-27
1997-10-21
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
4241891, 4242281, 435 5, 435 693, 435 701, 435 703, 4352402, 43524027, 4352351, 435239, C12Q 170
Patent
active
056793421
ABSTRACT:
The present invention is directed to extracorporeal cell systems infected with hepatitis C virus (HCV). The present invention also relates to products of such cell systems and their use as vaccines and in immunoassays. Methods whereby HCV-infected extracorporeal cell systems are constructed are included, and various immunoassays to detect HCV antibodies are also presented. The HCV-infected cell systems can be used to screen putative antiviral agents.
Houghton Michael
Steimer Kathelyn S.
Weiner Amy J.
Blackburn Robert P.
Chiron Corporation
Goldman Kenneth M.
Harbin Alisa A.
Nucker Christine M.
LandOfFree
Hepatitis C virus infected cell systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus infected cell systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus infected cell systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1004577